Any feedback?
Literature summary for 3.4.14.5 extracted from
- Effects of the combination of dipeptidyl peptidase-IV inhibitor ASP8497 and antidiabetic drugs in streptozotocin-nicotinamide-induced mildly diabetic mice (2009), Eur. J. Pharmacol., 605, 170-176.
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| ASP8497 | i.e. [(2S,4S)-4-fluoro-1-([4-methyl-1-(methylsulfonyl)piperidin-4-yl]amino]acetyl)pyrrolidine-2-carbonitrile monofumarate, the combination of 1 mg/kg ASP8497 with antidiabetic drugs can be useful for correcting the postprandial hyperglycemia seen with type 2 diabetes | Mus musculus |  |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Mus musculus | - |
- |
- |
Source Tissue
| Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|
| blood plasma | - |
Mus musculus | - |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| dipeptidyl peptidase-IV | - |
Mus musculus |
| DPPIV | - |
Mus musculus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
